ReviewGels (Basel, Switzerland)2024
A Review of Weak Gel Fracturing Fluids for Deep Shale Gas Reservoirs.
Review in Gels (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed.
- A Low-Polymer High-Temperature Water-Based Fracturing Gel Enabled by a Dual-Ligand Organic Zirconium Crosslinker: An Experimental Study.Gels (Basel, Switzerland) · 2026Article
- Preparation and properties of a hydrophobically associating friction reducer for fracturing in low-permeability gas reservoirs.Scientific reports · 2026Article
- Supramolecular Polymer-Based Delayed Crosslinking Weighted Fracturing Fluid with a Double Network for Ultra-Deep Reservoirs.Gels (Basel, Switzerland) · 2026Article
- Zwitterionic Polymer Gel Fracturing Fluid with Molecular Interface Regulation for Pretreatment-Free Flowback Recycling.Gels (Basel, Switzerland) · 2026Article
- Polyacrylamide-Based Polymers for Slickwater Fracturing Fluids: A Review of Molecular Design, Drag Reduction Mechanisms, and Gelation Methods.Gels (Basel, Switzerland) · 2026Review
- COScientific reports · 2026Article
- Mechanisms of Mobility Control and Enhanced Oil Recovery of Weak Gels in Heterogeneous Reservoirs.Gels (Basel, Switzerland) · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Low-viscosity slickwater fracturing fluids are a crucial technology for the commercial development of shallow shale gas. However, in deep shale gas formations with high pressure, a higher sand concentration is required to support fractures. Linear gel fracturing fluids and crosslinked gel fracturing fluids have a strong sand-carrying capacity, but the drag reduction effect is poor, and it needs to be pre-prepared to decrease the fracturing cost. Slick water fracturing fluids have a strong drag reduction effect and low cost, but their sand-carrying capacity is poor and the fracturing fluid sand ratio is low. The research and development of viscous slick water fracturing fluids solves this problem. It can be switched on-line between a low-viscosity slick water fracturing fluid and high-viscosity weak gel fracturing fluid, which significantly reduces the cost of single-well fracturing. A polyacrylamide drag reducer is the core additive of slick water fracturing fluids. By adjusting its concentration, the control of the on-line viscosity of fracturing fluid can be realized, that is, 'low viscosity for drag reduction, high viscosity for sand-carrying'. Therefore, this article introduces the research and application status of a linear gel fracturing fluid, crosslinked gel fracturing fluid, and slick water fracturing fluid for deep shale gas reservoirs, and focuses on the research status of a viscous slick water fracturing fluid and viscosity-controllable polyacrylamide drag reducer, with the aim of providing valuable insights for the research on water-based fracturing fluids in the stimulation of deep shale gas reservoirs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.